Skip to main content
. 2015 Apr 29;30(3):325–334. doi: 10.3904/kjim.2015.30.3.325

Table 4. Resistance to anti-tuberculosis drugs according to previously treated cases of relapse, TAI, and TAF (n = 314).

graphic file with name kjim-30-325-i004.jpg

Values are presented as number (%).

TAI, treatment after interruption; TAF, treatment after failure; MDR, multidrug-resistance; XDR, extensively drug-resistance; PAS, para-aminosalicylic acid.

aAmikacin sensitivity testing was performed in 288 cases.

bLevofloxacin sensitivity testing was performed in 249 cases.